| RS2522052892 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522053303 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522053584 |
ARID1A
|
Health Risk |
association |
Endometrial carcinoma, Endometrial carcinoma |
| RS2522053710 |
MECP2
|
Health Risk |
Likely pathogenic |
— |
| RS2522053774 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522054508 |
MECP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Developmental disorder |
| RS2522054547 |
MECP2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2522054622 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522055117 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522055324 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522055573 |
MECP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Syndromic X-linked intellectual disability Lubs type, Syndromic X-linked intellectual disability Lubs type |
| RS2522056044 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2522056444 |
MECP2
|
Health Risk |
Likely pathogenic |
— |
| RS2522056473 |
MECP2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2522056967 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Neuromuscular disease caused by qualitative or quantitative defects of dystrophin |
| RS2522057178 |
MECP2
|
Health Risk |
Likely pathogenic |
X-linked intellectual disability-psychosis-macroorchidism syndrome, Syndromic X-linked intellectual disability Lubs type |
| RS2522059013 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522060204 |
HUWE1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked syndromic |
| RS2522061549 |
COX7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2522062932 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2522062937 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522063583 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2522064270 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS2522065305 |
MECP2
|
Health Risk |
Likely pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522066395 |
MECP2
|
Health Risk |
Pathogenic |
MECP2-related disorder, MECP2-related disorder |
| RS2522066634 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522067436 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522067527 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522067867 |
MECP2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2522068012 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522068400 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522068701 |
MECP2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2522068996 |
MECP2
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2522069148 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS2522069950 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS2522070197 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522070698 |
MECP2
|
Health Risk |
Likely pathogenic |
— |
| RS2522071284 |
MECP2
|
Health Risk |
Pathogenic |
— |
| RS2522071496 |
MECP2
|
Health Risk |
Likely pathogenic |
— |
| RS2522071932 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS2522072280 |
AK2
|
Health Risk |
Pathogenic |
Reticular dysgenesis, Reticular dysgenesis |
| RS2522073088 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS2522073316 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS2522073630 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Rett syndrome |
| RS2522075107 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522075657 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522078030 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522079778 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522084197 |
SHOX
|
Health Risk |
Pathogenic |
Leri-Weill dyschondrosteosis, Leri-Weill dyschondrosteosis |
| RS2522085209 |
AHDC1
|
Health Risk |
Likely pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS2522085267 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS2522086284 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS2522086697 |
MECP2
|
Health Risk |
Likely pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522088735 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, X-linked intellectual disability-psychosis-macroorchidism syndrome |
| RS2522088775 |
RERE
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without anomalies of the brain, eye |
| RS2522088967 |
MECP2
|
Health Risk |
Likely pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522089054 |
MECP2
|
Health Risk |
Likely pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522089110 |
MECP2
|
Health Risk |
Likely pathogenic |
— |
| RS2522089740 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2522092007 |
GNB1
|
Health Risk |
Pathogenic |
— |
| RS2522096827 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2522100714 |
SHOX
|
Health Risk |
Pathogenic |
— |
| RS2522102022 |
SHOX
|
Health Risk |
Likely pathogenic |
Langer mesomelic dysplasia syndrome, Leri-Weill dyschondrosteosis |
| RS2522102153 |
SHOX
|
Health Risk |
Pathogenic |
— |
| RS2522102225 |
SHOX
|
Health Risk |
Pathogenic |
SHOX-related disorder, SHOX-related disorder |
| RS2522102328 |
SHOX
|
Health Risk |
Pathogenic |
Leri-Weill dyschondrosteosis, Leri-Weill dyschondrosteosis |
| RS2522102405 |
SHOX
|
Health Risk |
Likely pathogenic |
SHOX-related disorder, SHOX-related disorder |
| RS2522103731 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522103865 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522103909 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522106224 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS2522106375 |
CD40LG
|
Health Risk |
Pathogenic |
— |
| RS2522106457 |
MECP2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2522106494 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522106547 |
MECP2
|
Health Risk |
Pathogenic |
— |
| RS2522106594 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522106660 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS2522109882 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522110034 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS2522111057 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522111128 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS2522111616 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522111700 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522112977 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS2522114205 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522117677 |
CD40LG
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522117728 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522117745 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522117875 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522117925 |
CD40LG
|
Health Risk |
Likely pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522117947 |
CD40LG
|
Health Risk |
Likely pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522118161 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522118239 |
CD40LG
|
Health Risk |
Likely pathogenic |
— |
| RS2522118292 |
CD40LG
|
Health Risk |
Likely pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522118504 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522118643 |
CD40LG
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522118648 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS2522122969 |
MTM1
|
Health Risk |
Likely pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2522123139 |
MTM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2522131120 |
SHOX
|
Health Risk |
Likely pathogenic |
Nonpapillary renal cell carcinoma, Nonpapillary renal cell carcinoma |